Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 11/20 | 0.47 |
| ▸ | LTB4R2 | Q9NPC1 | 11/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4473046 | 1.00 | AGTR1 (0.47) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL30218406 | 0.86 | AGTR1 (0.48) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL5593137 | 0.86 | AGTR1 (0.48) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL2500 | 0.85 | LTB4R2 (0.49) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL30218387 | 0.85 | AGTR1 (0.45) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL2501 | 0.84 | LTB4R2 (0.49) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL3148 | 0.83 | AGTR1 (0.46) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL25964166 | 0.81 | AGTR1 (0.58) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL8242346 | 0.81 | AGTR1 (0.58) | AGTR1LTB4R2ABCB11GP6 | |
| SCHEMBL2635 | 0.80 | AGTR1 (0.71) | AGTR1LTB4R2ABCB11GP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203920-A1 | METHOD FOR ISOLATING 5-SUBSTITUTED TETRAZOLES | SANOCHEMIA PHARMAZEUTIKA AG (AT) | 2009-08-13 | — | — | US | disclosed |
| EP-1910251-A1 | METHOD FOR ISOLATING 5-SUBSTITUTED TETRAZOLES | Sanochemia Pharmazeutika Aktiengesellschaft (AT) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007014412-A1 | METHOD FOR ISOLATING 5-SUBSTITUTED TETRAZOLES | SANOCHEMIA PHARMAZEUTIKA AG (AT) | 2007-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203920-A1 | METHOD FOR ISOLATING 5-SUBSTITUTED TETRAZOLES | TH, CASP5, TYR | AGTR1 1702/4885LTB4R2 775/4885ABCB11 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.